These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20979828)

  • 1. [Clinical study of resiniferatoxin on neurogenic bladder].
    Liu TJ; Zhao MJ; Sha KF; Gao JZ
    Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(26):1827-9. PubMed ID: 20979828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the intravesical resiniferatoxin instillation evaluated by the ice provocative urodynamic study.
    Shin JC; Kim YW; Park CI; Kang SW; Yang SC
    Spinal Cord; 2006 May; 44(5):309-14. PubMed ID: 16186855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.
    Silva C; Silva J; Ribeiro MJ; Avelino A; Cruz F
    Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.
    Giannantoni A; Di Stasi SM; Stephen RL; Bini V; Costantini E; Porena M
    J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity.
    Watanabe T; Yokoyama T; Sasaki K; Nozaki K; Ozawa H; Kumon H
    Int J Urol; 2004 Apr; 11(4):200-5. PubMed ID: 15028097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions.
    Kuo HC
    J Urol; 2003 Sep; 170(3):835-9. PubMed ID: 12913711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical therapy options for neurogenic detrusor overactivity.
    Reitz A; Schurch B
    Spinal Cord; 2004 May; 42(5):267-72. PubMed ID: 14758352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction.
    Cruz F; Guimarães M; Silva C; Rio ME; Coimbra A; Reis M
    J Urol; 1997 Feb; 157(2):585-9. PubMed ID: 8996364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin.
    Apostolidis A; Brady CM; Yiangou Y; Davis J; Fowler CJ; Anand P
    Urology; 2005 Feb; 65(2):400-5. PubMed ID: 15708075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies of urodynamics. VIII. Clinical and experimental studies of effects of prostaglandin E2 and prostaglandin F2 alpha on lower urinary tract (author's transl)].
    Kaneko S; Kato Y; Tsujihashi H; Boku E; Kunikata S; Kataoka K; Nagai N; Matsuura T; Yachiku S; Kurita T
    Nihon Hinyokika Gakkai Zasshi; 1981 Oct; 72(10):1221-6. PubMed ID: 6948976
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of anticholinergics on bladder tonus and on the voiding function].
    Kelly LU; Wehnert J
    Z Urol Nephrol; 1979 Oct; 72(10):765-9. PubMed ID: 532394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment on: Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
    Novara G
    Eur Urol; 2008 Mar; 53(3):618-9. PubMed ID: 17804151
    [No Abstract]   [Full Text] [Related]  

  • 13. Detrusor supersensitivity to 15 (S) 15-methyl prostaglandin F2-alpha in chronic neurogenic vesical dysfunction.
    Vaidyanathan S; Rao MS; Mapa MK; Rao K; Sharma PL; Chary KS
    Indian J Med Res; 1982 Jun; 75():839-45. PubMed ID: 7129556
    [No Abstract]   [Full Text] [Related]  

  • 14. Autonomous contractile activity in the isolated rat bladder is modulated by a TRPV1 dependent mechanism.
    Gevaert T; Vandepitte J; Ost D; Nilius B; De Ridder D
    Neurourol Urodyn; 2007; 26(3):424-32; discussion 451-3. PubMed ID: 17004230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of transient receptor potential vanilloid subfamily 1 in the bladder predicts the response to intravesical instillations of resiniferatoxin in patients with refractory idiopathic detrusor overactivity.
    Liu HT; Kuo HC
    BJU Int; 2007 Nov; 100(5):1086-90. PubMed ID: 17711510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation.
    Apostolidis A; Gonzales GE; Fowler CJ
    Eur Urol; 2006 Dec; 50(6):1299-305. PubMed ID: 16697519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurogenic bladder: pathophysiology of the disorder of compliance].
    Chartier-Kastler E; Ayoub N; Even-Schneider A; Richard F; Soler JM; Denys P
    Prog Urol; 2004 Sep; 14(4):472-8. PubMed ID: 15776894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Validation of the treatment of the neurogenic bladder in children with myelodysplasia using pikamilon].
    Vishnevskiĭ EL; Guseva NB
    Urol Nefrol (Mosk); 1998; (2):27-30. PubMed ID: 9577700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic effects of intravesical resiniferatoxin and capsaicin in conscious rats with and without outflow obstruction.
    Ishizuka O; Mattiasson A; Andersson KE
    J Urol; 1995 Aug; 154(2 Pt 1):611-6. PubMed ID: 7609147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical electromotive botulinum toxin type A administration: part I--Experimental study.
    Kajbafzadeh AM; Montaser-Kouhsari L; Ahmadi H; Sotoudeh M
    Urology; 2011 Jun; 77(6):1460-4. PubMed ID: 21168901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.